Back to Explorer

Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling : Guidance for Industry and Food and Drug Administration Staff

FinalCenter for Devices and Radiological Health03/17/2015

Description

Thisguidanceprovides recommendations for the formulation and scientific validation of reprocessing instructions for reusable medical devices. This guidance document also provides recommendations for the content and review of premarket notification submissions [510(k)], premarket approval (PMA) applications, humanitarian device exemption (HDE) applications, de novo requests and investigational device exemption (IDE) applications, concerning the labeling instructions for reprocessing reusable medical devices. Please note that exemption from 510(k) does not mean a device is exempt from compliance with labeling or Quality Management System Regulation (QMSR) requirements. Manufacturers of 510(k)-exempt devices should follow the recommendations of this guidance pertaining to such requirements, unless, for example, the device is specifically exempted by regulation from specific QMSR requirements.

Scope & Applicability

Product Classes

10
Reusable Medical Device

A device intended for repeated use with appropriate cleaning and reprocessing.

Arthroscopes

Endoscopes requiring validation data if flexible

Duodenoscope

Example of a device with reprocessing safety signals

Bronchoscopes

Flexible or rigid bronchoscopes and accessories

Single-use Device

A device that is intended for one use or on a single patient during a single procedure.

Class III Device

Generally recommended for Enhanced Documentation; Regulatory classification mentioned for implantable sensors and HPV tests; Mentioned in the context of an in vitro nucleic acid test for CMV DNA.

Reusable Device

You should identify the device as reusable or reusable, after 24-hour multi-patient use

Class II medical devices

Many sterilization accessories used in reprocessing reusable devices in health care settings are class II medical devices; manufacturers must establish and maintain procedures for validating the design

Non-Critical Devices

devices contacting only intact skin

Semi-Critical Devices

devices contacting intact mucous membranes or non-intact skin

Stakeholders

2
Manufacturer

Entity responsible for submitting NDINs

Professional Staff

representative participants for validation studies

Regulatory Context

Attributes

5
Extended cycle

The expression extended cycle has gained common usage to describe any sterilization cycle that includes specifications that deviate

Sterility Assurance Level

Quality parameter that must remain unchanged for the policy

Sterility assurance level (SAL) of 10⁻⁶

Recommended level for device sterilization

Worst-case

Refers to device sizes with highest corrosion susceptibility or largest surface area.

Reuse Life

The labeling should either 1) inform the user how many times the device can be reused

Identified Hazards

Hazards

7
Transmissible spongiform encephalopathy (TSE) agents

Prions requiring specific inactivation processes

Patient infections

High risk if devices are not adequately reprocessed

Microbial transmission

Risk associated with inadequately reprocessed devices

Sterilant Residuals

Labeling should include instructions for reducing sterilant residuals

Bacterial endotoxins

risk of febrile reaction addressed by pyrogenicity testing

Microbial growth

Delays may create conditions favorable to microbial growth

Microbiological Contamination

Environmental factors affecting biological products

Related CFR Sections (11)

Related Warning Letters (10)

  • CGMP/QSR/Medical Devices/Adulterated

    Envoy Medical Inc.

    2025-12-09
  • CGMP/QSR/Medical Devices/Adulterated

    Hong Qiangxing Shenzhen Electronics Limited

    2025-11-25
  • CGMP/QSR/Medical Devices/Adulterated

    Contec Medical Systems Co., Ltd.

    2025-10-28
  • CGMP/QSR/Medical Devices/Adulterated/Misbranded

    Royal Philips

    2025-10-28
  • CGMP/QSR/Medical Devices/Adulterated/Misbranded

    Qianjiang Kingphar Medical Material Co Ltd.

    2025-10-28
  • CGMP/QSR/Medical Devices/Adulterated

    LEVO AG

    2025-10-21
  • CGMP/QSR/Medical Devices/Adulterated

    Technological Medical Advancements LLC

    2025-10-07
  • Medical Device/Adulterated/Misbranded/Lacks PMA and/or 510(k)

    The Richline Group, Inc.

    2025-09-23
  • Investigational Device Exemptions (IDE)/Premarket Approval Application (PMA) Adulterated Device

    SeniorLife Technologies, Inc.

    2025-09-16
  • CGMP/QSR/Medical Devices/Adulterated

    Miach Orthopaedics

    2025-08-26

See Also (8)